Chapter title |
Emerging Target Families: Intractable Targets.
|
---|---|
Chapter number | 28 |
Book title |
New Approaches to Drug Discovery
|
Published in |
Handbook of experimental pharmacology, November 2015
|
DOI | 10.1007/164_2015_28 |
Pubmed ID | |
Book ISBNs |
978-3-31-928912-0, 978-3-31-928914-4
|
Authors |
Knapp, Stefan, Stefan Knapp |
Abstract |
The druggability of a target is defined by the likelihood of a certain target binding site to be amendable to functional modulation by a small molecule in vivo. Thus, druggability depends on the ability of the developed small molecule to reach the target site, the properties of the ligand binding pocket and our ability to develop chemical matter that efficiently interact with the drug binding site of interest. Historically enzymes have been the main drug targets because the inhibition of their activity can be easily assayed and catalytic centres are often attractive drug binding sites. However, despite considerable effort, a number of classical enzyme families have not been successfully targeted. More recently protein-protein interactions received considerable attention and several clinical inhibitors have now been developed. Despite the considerable progress made expanding target space, a large number of targets with a very strong rationale for targeting remain intractable. In the following chapter I will summarize progress made in developing inhibitors for challenging drug binding sites and emerging target families. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 10% |
Unknown | 9 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 30% |
Student > Ph. D. Student | 2 | 20% |
Professor | 1 | 10% |
Other | 1 | 10% |
Unknown | 3 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 3 | 30% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 20% |
Biochemistry, Genetics and Molecular Biology | 1 | 10% |
Physics and Astronomy | 1 | 10% |
Unknown | 3 | 30% |